Capecitabine

Home > API & Intermediate > Antineoplastic Agents > Capecitabine Manufacturers > Capecitabine

Capecitabine

CAS NO.： 154361-50-9

FOB Price： NEGOTIABLE Get Latest Price

Specification： ≥99%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Capecitabine

Product Name:Capecitabine

Chinese Name:卡培他滨

CAS NO.：154361-50-9

Molecular formula:C15H22FN3O6

Molecular weight: 359.35

Specification content: ≥ 99%

Properties

Capecitabine, an antimetabolite fluoropyrimidine deoxynucleoside carbamate that can be converted to 5-FU in vivo, was developed by Roche under the trade name hiloda and is able to inhibit cell division and interfere with RNA and protein synthesis. For further treatment of paclitaxel and advanced primary or metastatic breast cancer including patients refractory to chemotherapeutic regimens with anthracyclines. It is mainly used for the treatment of advanced primary or metastatic breast, rectal, colon and gastric cancer.

CAS No.

154361-50-9

Formula

C15H22FN3O6

Molecular Mass

359.35000

Exact Mass

359.14900

PSA

122.91000

Logp

0.83320

IUPAC

pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

Matter Classification

organic

Category

Melting Point

110-121°C

Density

1.49±0.1 g/cm3(Predicted)

Boiling Point

437.874ºC at 760 mmHg

Flash Point

218.619ºC

Appearance

Colorless solid

HS Code

29349990

UN No.

0.0

DG-Class

0.0

Risk Code

45-60-61-68

Safety Label

Send your message to this supplier

To：

Chongqing Beisheng Pharmaceutical Co.,Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

b

Send Email

Capecitabine